NTRK1 and cancer: Indeed, cell-bound GD2 and GD3 appear to be etiological to cancer onset or progression, lower the threshold for activation of receptor tyrosine kinases, and cause immune suppression allowing tumors to evade immune responses (14, 16, 17).